查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1576953

侧流读取/化验 - 市场考察，竞争情形，市场预测(2030年)

Lateral Flow Readers/Assays - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

2023年全球侧流读取/分析市场规模为86.4亿美元，预计2030年将达到121.5亿美元，预测期间2024-2030年复合年增长率为5.41%。由于爱滋病毒、乙型肝炎、丙型肝炎和流感等传染病患者数量的增加，以及各大公司创新新产品的推出，该市场呈现显着增长，预计从 2024 年将增加到2030年。推动该时期整体市场成长的主要因素。

侧流读取/侦测市场动态

根据世界卫生组织（WHO）2024年的公告，2022年全球约有3,900万人感染爱滋病毒。该文件还指出，大约有 3750 万人是成年人（15 岁以上），大约 150 万人是 15 岁以下的儿童。传染病诊断对于识别 HIV 感染并实现早期检测、治疗监测和传播预防至关重要。侧向层析阅读器/检测是 HIV 诊断的重要工具，可快速、即时检测 HIV 抗体和抗原。能够及早发现感染，以便及时介入和治疗监测。

根据世界卫生组织（2024）数据，2022年全球将有3.04亿人感染B型/C型肝炎。侧向层析阅读器/检测用于透过检测血液或血清样本中的特定抗原或抗体来快速有效地诊断乙型/丙型肝炎。这些测试可以在护理点快速提供结果，从而能够及早发现和监测感染，特别是在资源有限的环境中。

此外，市场参与者推出创新新产品正在提高同类产品的市场占有率。例如，2023年2月，赛默飞在印度推出了用于传染病检测的即时PCR试剂盒。 Applied Biosystems 的TaqPath PCR 试剂盒用于分析多重抗药性结核病(MDR-TB)、结核分枝桿菌复合体(MTB)、乙型肝炎(HBV)、C型肝炎(HCV)、HIV 和HLA -B27 等基因旨在为诊断的开发和测试提供可靠性和信心。

因此，在 2024-2030 年预测期内，所有上述因素的交互作用预计将推动侧流读数仪/检测市场的发展。

然而，开发准确的诊断测试和设备、替代程序的可用性等方面的课题可能会限制侧流读取器/分析市场的成长。

侧向层析阅读器/分析市场区隔分析

在侧流读取器/检测市场的产品领域中，试剂盒和试剂类别预计将在 2023 年占据主要收入占有率。侧流读数器/检测试剂盒和试剂的快速增长是由于其广泛使用的方法提供了多种独特的功能和优点，使它们成为首选。

这些试剂盒通常包括侧流测试条、样品製备试剂，有时还包括进行测定所需的缓衝液和稀释剂。这些试剂盒和试剂具有简单、方便和多功能的特点。它专为护理点使用而设计，不需要复杂的测试基础设施，非常适合在诊所、医院甚至家庭诊断等各种环境中进行快速测试。

侧流试剂盒和试剂的主要特点是能够检测特定的生物标记、抗原或抗体，可用于诊断传染病（COVID-19、HIV、疟疾等）、诊断性慢性病（如糖化血红素）适用于监测心臟事件（例如检测糖尿病）和评估心臟事件（例如检测心臟病发作病例中的肌钙蛋白水平）。此外，这些套件通常针对特定目标进行预先配置，这意味着它们对于所测试的条件具有高度特异性。然而，灵敏度可能因所用试剂的设计和品质而异。

因此，由于上述因素，对试剂盒和试剂类别的需求将激增，因此，在2024-2030 年预测期内，该类别预计将出现相当大的增长，并增加对侧向层析读取器/检测的需求. 为整体市场成长做出贡献。

本报告提供全球侧流读取/化验市场相关调查分析，提供各地区市场规模与预测，过去3年的产品/技术开发，市场主要企业，未来的机会等资讯。

目录

第1章 侧流读取/化验市场报告的简介

第2章 侧流读取/化验市场摘要整理

  • 市场概要

第3章 竞争情形

第4章 法规分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第5章 侧流读取/化验市场主要原因的分析

  • 侧流读取/化验市场促进因素
  • 侧流读取/化验市场阻碍因素与课题
  • 侧流读取/化验市场机会

第6章 侧流读取/化验市场波特的五力分析

第7章 侧流读取/化验市场评估

  • 各产品
    • 领导者
    • 套件·试剂
  • 各技术
    • 三明治化验
    • 竞争化验
    • 多工检测化验
  • 各用途
    • 临床试验
    • 医药品开发·品质检验
    • 其他
  • 各终端用户
    • 医院·诊疗所
    • 居家照护
  • 地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他地区

第8章 侧流读取/化验市场企业与产品的简介

  • Abbott
  • Quidel Corporation
  • Danaher Corporation
  • Siemens Healthineers
  • F. Hoffman-La Roche AG
  • LumiraDx
  • BD
  • Eurofins Technologies
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific
  • Hologic, Inc.
  • PerkinElmer Inc.
  • QIAGEN
  • Merck KGaA
  • OPERON
  • Abingdon Health
  • DIALUNOX
  • 3B BlackBio Biotech India Ltd.
  • ADS Biotec Inc.

第9章 KOL的见解

第10章 计划的方法

第11章 关于DelveInsight

第12章 免责声明，咨询方式

Product Code: DIMDCL0530

Lateral Flow Readers/Assay Market by Product (Readers [Bench-top Readers, Digital/Mobile Readers], and Kits & Reagents), Technique (Sandwich Assays, Competitive Assays, and Multiplex Detection Assays), Application (Clinical Testing [Pregnancy Testing, Infectious Diseases Testing, Cardiac Marker Testing, and Others], Drug Development & Quality Testing, and Others), End-User (Hospitals & Clinics, Home Care, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2030 owing to the growing instances of infectious diseases and rising product developmental activities worldwide

The lateral flow readers/assay market was valued at USD 8.64 billion in 2023, growing at a CAGR of 5.41% during the forecast period from 2024 to 2030 to reach USD 12.15 billion by 2030. The lateral flow readers/assay market is experiencing significant growth due to the increasing cases of infectious diseases including HIV, hepatitis B & C, and influenza, the introduction of new and innovative products by key players, and others that are acting as major factors contributing to the overall growth of the lateral flow readers/assay market during the forecast period from 2024 to 2030.

Lateral Flow Readers/Assay Market Dynamics:

As per the World Health Organization (WHO) 2024, nearly 39 million people were living with HIV infection in 2022, globally. The source also stated that nearly 37.5 million were adults (aged 15 and above) and approximately 1.5 million people were children, aged less than 15 years. Infectious disease diagnostics are crucial in identifying HIV infection, enabling early detection, treatment monitoring, and preventing transmission. Lateral flow readers/assays are essential tools in HIV diagnostics, offering rapid, point-of-care detection of HIV antibodies or antigens. They enable early identification of infection, allowing for timely intervention and treatment monitoring.

Data from the WHO 2024, stated that 304 million people were infected by hepatitis B and C across the world in the year 2022. The same source further stated that out of these 254 million were afflicted by hepatitis B and 50 million were affected by hepatitis C. Lateral flow readers/assays are used to quickly and efficiently diagnose hepatitis B and C by detecting specific antigens or antibodies in blood or serum samples. These tests provide rapid results at the point of care, enabling early detection and monitoring of infections, particularly in resource-limited settings.

Additionally, the introduction of new and innovative products by market players are pushing forward the market share for same. For example, in February 2023, Thermo Fisher introduced real-time PCR kits in India for the detection of infectious diseases. The Applied Biosystems TaqPath PCR kits are designed to provide confidence and reliability in diagnostic development and testing for conditions like Multi-Drug Resistant Tuberculosis (MDR-TB), M. Tuberculosis complex (MTB), Hepatitis B (HBV), Hepatitis C (HCV), HIV, and for genetic analysis such as HLA-B27.

Hence, the interplay of all the above-mentioned factors is expected to drive the lateral flow readers/assay market during the given forecast period from 2024 to 2030.

However, challenges in the development of accurate diagnostic tests and equipment, and the availability of alternative procedures, among others may restrict the market growth for the lateral flow readers/assay market.

Lateral Flow Readers/Assay Market Segment Analysis:

Lateral Flow Readers/Assay Market by Product (Readers [Bench-top Readers, Digital/Mobile Readers], and Kits & Reagents), Technique (Sandwich Assays, Competitive Assays, and Multiplex Detection Assays), Application (Clinical Testing [Pregnancy Testing, Infectious Diseases Testing, Cardiac Marker Testing, and Others], Drug Development & Quality Testing, and Others), End-User (Hospitals & Clinics, Home Care, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the lateral flow readers/assay market, the kits & reagents category is expected to have a significant revenue share in the year 2023. The rapid growth of the kits & reagents of lateral flow readers/assay is due to its widely utilized approach that offers several distinctive features and benefits, making it a preferred option for people.

These kits typically include the lateral flow test strips, reagents for sample preparation, and sometimes buffers or diluents necessary for running the assay. The distinctive features of these kits and reagents lie in their simplicity, convenience, and versatility. Designed for point-of-care use, they do not require complex laboratory infrastructure, which makes them ideal for rapid testing in various settings such as clinics, hospitals, and even home diagnostics.

A key feature of lateral flow kits and reagents is their ability to detect specific biomarkers, antigens, or antibodies, making them suitable for diagnosing infectious diseases (such as COVID-19, HIV, or malaria), monitoring chronic conditions (like diabetes through glycated hemoglobin detection), and assessing cardiac events (e.g., detecting troponin levels in heart attack cases). Moreover, these kits are typically pre-configured for a specific target, meaning they are highly specific to the condition being tested for. However, sensitivity can vary depending on the design and quality of the reagents used.

Therefore, owing to the factors mentioned earlier, the demand for the kits & reagents category upsurges, thereby the category is expected to witness considerable growth eventually contributing to the overall growth of the lateral flow readers/assay market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall lateral flow readers/assay market:

Among all the regions, North America is estimated to hold a significant revenue share in the lateral flow readers/assay market. This domination is due to the growing burden of infectious diseases including tuberculosis, outbreaks of influenza, emerging pathogens, growing product developmental activities, presence of key manufacturers, among others that are expected to fuel the lateral flow readers/assay market in the region during the forecast period from 2024 to 2030.

Public Health Agency of Canada (2024), stated that in 2022, there were 1,971 active tuberculosis cases in Canada. Lateral flow readers/assays are used in tuberculosis diagnostics to provide rapid, point-of-care detection of TB antigens or antibodies. These tests help identify active TB cases by detecting Mycobacterium tuberculosis-specific proteins, aiding in early diagnosis and timely treatment.

Advancements in technology, such as the development of rapid diagnostic tests and molecular assays, enhance the accuracy and speed of diagnoses, making testing more accessible. The increase in point-of-care testing is also contributing to the market, allowing immediate results in clinical settings.

Rising product developmental activities by regulatory bodies in the region are likely to push forward the revenue shares for the same. For example, in November 2023, Abbott announced that it received the U.S. Food and Drug Administration (FDA) approval for its human papillomavirus or HPV screening solution.

Therefore, the interplay of all the factors mentioned above would provide a conducive growth environment for the North America region in the lateral flow readers/assay market during the forecast period from 2024 to 2030.

Lateral Flow Readers/Assay Market key players:

Some of the key market players operating in the lateral flow readers/assay market include Abbott, Quidel Corporation, Danaher Corporation, Siemens Healthineers, F. Hoffman-La Roche AG, LumiraDx, BD, Eurofins Technologies, bioMerieux SA, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Hologic, Inc., PerkinElmer Inc., QIAGEN, Merck KGaA, OPERON, Abingdon Health, DIALUNOX, 3B BlackBio Biotech India Ltd., ADS Biotec Inc., and others.

Recent Developmental Activities in the Lateral Flow Readers/Assay Market:

  • In January 2021, LumiraDx announced multinational approvals of its SARS-CoV-2 Antigen Test. With approvals in Japan and Brazil, the fast, accurate LumiraDx SARS-CoV-2 Antigen Test was made available to patients in more than 30 nations worldwide.
  • In January 2021, ADS Biotec announced the European launch and immediate availability of its COVID-19 Rapid Antigen Test. The company obtained a CE mark for the industry's first Rapid Antigen Test that works with both nasal swabs and blood serum, using proven fluorescence immunochromatographic lateral flow technology, providing an easy-to-use test for COVID-19 infection within 15 minutes.

Key takeaways from the Lateral Flow Readers/Assay market report study

  • Market size analysis for current lateral flow readers/assay market size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the lateral flow readers/assay market
  • Various opportunities available for the other competitors in the lateral flow readers/assay market space
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current lateral flow readers/assay market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for lateral flow readers/assay market growth in the coming future?

Target audience who can be benefited from this Lateral Flow Readers/Assay market report study

  • Lateral flow readers/assay device providers
  • Research organizations and consulting companies
  • Lateral flow readers/assay related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in lateral flow readers/assay
  • Various end-users who want to know more about the lateral flow readers/assay market and the latest developments in the lateral flow readers/assay market

Frequently Asked Questions for the Lateral Flow Readers/Assay Market:

1. What are Lateral Flow Readers/Assay?

  • The lateral flow readers/assay are simple diagnostic devices that are used to confirm the presence or absence of a target analyte, such as pathogens or biomarkers in humans or animals, or contaminants in water supplies, foodstuffs, or animal feeds. The most commonly known type of lateral flow rapid test strip is the pregnancy test.

2. What is the market for Lateral Flow Readers/Assay?

  • The lateral flow readers/assay market was valued at USD 8.64 billion in 2023, growing at a CAGR of 5.41% during the forecast period from 2024 to 2030 to reach USD 12.15 billion by 2030.

3. What are the drivers for the Lateral Flow Readers/Assay market?

  • The lateral flow readers/assay market is experiencing significant growth due to the increasing cases of infectious diseases including HIV, hepatitis B & C, and influenza, the introduction of new and innovative products by key players, and others that are acting as major factors contributing to the overall growth of the lateral flow readers/assay market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the Lateral Flow Readers/Assay market?

  • Some of the major market key players operating in the lateral flow readers/assay market include Abbott, Quidel Corporation, Danaher Corporation, Siemens Healthineers, F. Hoffman-La Roche AG, LumiraDx, BD, Eurofins Technologies, bioMerieux SA, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Hologic, Inc., PerkinElmer Inc., QIAGEN, Merck KGaA, OPERON, Abingdon Health, DIALUNOX, 3B BlackBio Biotech India Ltd., ADS Biotec Inc., and others.

5. Which region has the highest share in the Lateral Flow Readers/Assay market?

Among all the regions, North America is estimated to hold a significant revenue share in the lateral flow readers/assay market. This domination is due to the growing burden of infectious diseases including tuberculosis, outbreaks of influenza, emerging pathogens, growing product developmental activities, presence of key manufacturers, among others that are expected to fuel the lateral flow readers/assay market in the region during the forecast period from 2024 to 2030.

Table of Contents

1. Lateral Flow Readers/Assay Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Lateral Flow Readers/Assay Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Lateral Flow Readers/Assay Market Key Factors Analysis

  • 5.1. Lateral Flow Readers/Assay Market Drivers
    • 5.1.1. Growing instances of infectious diseases
    • 5.1.2. Rising cardiovascular disorders
    • 5.1.3. Increasing pregnancy diagnostics
    • 5.1.4. Rising product developmental activities
  • 5.2. Lateral Flow Readers/Assay Market Restraints and Challenges
    • 5.2.1. Challenges in the development of accurate diagnostic tests and equipment
    • 5.2.2. Availability of alternative procedure
  • 5.3. Lateral Flow Readers/Assay Market Opportunities
    • 5.3.1. Integration of AI and ML for data interpretation
    • 5.3.2. Biomarker expansion for early infectious disease detection

6. Lateral Flow Readers/Assay Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Lateral Flow Readers/Assay Market Assessment

  • 7.1. By Product
    • 7.1.1. Readers
      • 7.1.1.1. Bench-top Readers
      • 7.1.1.2. Digital/Mobile Readers
    • 7.1.2. Kits & Reagents
  • 7.2. By Technique
    • 7.2.1. Sandwich Assays
    • 7.2.2. Competitive Assays
    • 7.2.3. Multiplex Detection Assays
  • 7.3. By Application
    • 7.3.1. Clinical Testing
      • 7.3.1.1. Pregnancy Testing
      • 7.3.1.2. Infectious Diseases Testing
      • 7.3.1.3. Cardiac Marker Testing
      • 7.3.1.4. Others
    • 7.3.2. Drug Development & Quality Testing
    • 7.3.3. Others
  • 7.4. By End-User
    • 7.4.1. Hospitals & Clinics
    • 7.4.2. Home Care
    • 7.4.3. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. United States Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
      • 7.5.1.2. Canada Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
      • 7.5.1.3. Mexico Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
    • 7.5.2. Europe
      • 7.5.2.1. France Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
      • 7.5.2.2. Germany Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
      • 7.5.2.3. United Kingdom Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
      • 7.5.2.4. Italy Lateral Flow Readers/Assay market size in USD million (2021-2030)
      • 7.5.2.5. Spain Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
      • 7.5.2.6. Rest of Europe Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. China Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
      • 7.5.3.2. Japan Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
      • 7.5.3.3. India Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
      • 7.5.3.4. Australia Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
      • 7.5.3.5. South Korea Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
      • 7.5.3.6. Rest of Asia-Pacific Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. Middle East Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
      • 7.5.4.2. Africa Lateral Flow Readers/Assay Market Size in USD million (2021-2030)
      • 7.5.4.3. South America Lateral Flow Readers/Assay Market Size in USD million (2021-2030)

8. Lateral Flow Readers/Assay Market Company and Product Profiles

  • 8.1. Abbott
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Quidel Corporation
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Danaher Corporation
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Siemens Healthineers
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. F. Hoffman-La Roche AG
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. LumiraDx
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. BD
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Eurofins Technologies
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. bioMerieux SA
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Bio-Rad Laboratories, Inc.
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Thermo Fisher Scientific
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Hologic, Inc.
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. PerkinElmer Inc.
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. QIAGEN
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Merck KGaA
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. OPERON
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Abingdon Health
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. DIALUNOX
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. 3B BlackBio Biotech India Ltd.
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. ADS Biotec Inc.
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Lateral Flow Readers/Assay Market in Global (2021-2030)
  • Table 3: Lateral Flow Readers/Assay Market in Global by Product (2021-2030)
  • Table 4: Lateral Flow Readers/Assay Market in Global by Technique (2021-2030)
  • Table 5: Lateral Flow Readers/Assay Market in Global by Application (2021-2030)
  • Table 6: Lateral Flow Readers/Assay Market in Global by End-User (2021-2030)
  • Table 7: Lateral Flow Readers/Assay Market in Global by Geography (2021-2030)
  • Table 8: Lateral Flow Readers/Assay Market in North America (2021-2030)
  • Table 9: Lateral Flow Readers/Assay Market in the United States (2021-2030)
  • Table 10: Lateral Flow Readers/Assay Market in Canada (2021-2030)
  • Table 11: Lateral Flow Readers/Assay Market in Mexico (2021-2030)
  • Table 12: Lateral Flow Readers/Assay Market in Europe (2021-2030)
  • Table 13: Lateral Flow Readers/Assay Market in France (2021-2030)
  • Table 14: Lateral Flow Readers/Assay Market in Germany (2021-2030)
  • Table 15: Lateral Flow Readers/Assay Market in United Kingdom (2021-2030)
  • Table 16: Lateral Flow Readers/Assay Market in Italy (2021-2030)
  • Table 17: Lateral Flow Readers/Assay Market in Spain (2021-2030)
  • Table 18: Lateral Flow Readers/Assay Market in the Rest of Europe (2021-2030)
  • Table 19: Lateral Flow Readers/Assay Market in Asia-Pacific (2021-2030)
  • Table 20: Lateral Flow Readers/Assay Market in China (2021-2030)
  • Table 21: Lateral Flow Readers/Assay Market in Japan (2021-2030)
  • Table 22: Lateral Flow Readers/Assay Market in India (2021-2030)
  • Table 23: Lateral Flow Readers/Assay Market in Australia (2021-2030)
  • Table 24: Lateral Flow Readers/Assay Market in South Korea (2021-2030)
  • Table 25: Lateral Flow Readers/Assay Market in Rest of Asia-Pacific (2021-2030)
  • Table 26: Lateral Flow Readers/Assay Market in the Rest of the World (2021-2030)
  • Table 27: Lateral Flow Readers/Assay Market in the Middle East (2021-2030)
  • Table 28: Lateral Flow Readers/Assay Market in Africa (2021-2030)
  • Table 29: Lateral Flow Readers/Assay Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Lateral Flow Readers/Assay Market in Global (2021-2030)
  • Figure 3: Lateral Flow Readers/Assay Market in Global by Product (2021-2030)
  • Figure 4: Lateral Flow Readers/Assay Market in Global by Technique (2021-2030)
  • Figure 5: Lateral Flow Readers/Assay Market in Global by Application (2021-2030)
  • Figure 6: Lateral Flow Readers/Assay Market in Global by End-User (2021-2030)
  • Figure 7: Lateral Flow Readers/Assay Market in Global by Geography (2021-2030)
  • Figure 8: Lateral Flow Readers/Assay Market in North America (2021-2030)
  • Figure 9: Lateral Flow Readers/Assay Market in the United States (2021-2030)
  • Figure 10: Lateral Flow Readers/Assay Market in Canada (2021-2030)
  • Figure 11: Lateral Flow Readers/Assay Market in Mexico (2021-2030)
  • Figure 12: Lateral Flow Readers/Assay Market in Europe (2021-2030)
  • Figure 13: Lateral Flow Readers/Assay Market in France (2021-2030)
  • Figure 14: Lateral Flow Readers/Assay Market in Germany (2021-2030)
  • Figure 15: Lateral Flow Readers/Assay Market in United Kingdom (2021-2030)
  • Figure 16: Lateral Flow Readers/Assay Market in Italy (2021-2030)
  • Figure 17: Lateral Flow Readers/Assay Market in Spain (2021-2030)
  • Figure 18: Lateral Flow Readers/Assay Market in the Rest of Europe (2021-2030)
  • Figure 19: Lateral Flow Readers/Assay Market in Asia-Pacific (2021-2030)
  • Figure 20: Lateral Flow Readers/Assay Market in China (2021-2030)
  • Figure 21: Lateral Flow Readers/Assay Market in Japan (2021-2030)
  • Figure 22: Lateral Flow Readers/Assay Market in India (2021-2030)
  • Figure 23: Lateral Flow Readers/Assay Market in Australia (2021-2030)
  • Figure 24: Lateral Flow Readers/Assay Market in South Korea (2021-2030)
  • Figure 25: Lateral Flow Readers/Assay Market in Rest of Asia-Pacific (2021-2030)
  • Figure 26: Lateral Flow Readers/Assay Market in the Rest of the World (2021-2030)
  • Figure 27: Lateral Flow Readers/Assay Market in the Middle East (2021-2030)
  • Figure 28: Lateral Flow Readers/Assay Market in Africa (2021-2030)
  • Figure 29: Lateral Flow Readers/Assay Market in South America (2021-2030)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Marker Opportunities
  • Figure 33: PORTER'S Five Force Analysis